Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA ... - BioSpace

Retrieved on: 2022-11-08 22:09:24

Tags for this article:

Cancer

Medicine

Medical specialties

Merkel cell polyomavirus

Polyomaviridae

Immunogenicity

Merkel-cell carcinoma

Merkel

u.s. food and drug administration

ROCKVILLE

Click the tags to see associated articles and topics

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA ... - BioSpace. View article details on hiswai:

Excerpt

Immunomic Therapeutics Receives FDA Fast Track Designation for ITI-3000, a pDNA Vaccine, in Development for the Treatment of Merkel Cell Carcinoma ...

Article found on: www.biospace.com

View Original Article